Annual dialysis data report 2018, JSDT Renal Data Registry: dialysis fluid quality, hemodialysis and hemodiafiltration, peritoneal dialysis, and diabetes

Renal Replacement Therapy

Masanori Abe¹  Norio Hanafusa²  Minako Wakasugi²  Kosaku Nitta²  Shunsuke Goto²  Shigeru Nakai²  Ikuto Masakane²  Takeshi Hasegawa²  Nobuhiko Joki²  Takayuki Hamano²  Atsushi Wada²  Junichi Hoshino²  Keiichi Yamamoto²  Masatomo Taniguchi²  Hidetomo Nakamoto² 

[1] Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, 30-1, Oyaguchi Kami-cho, Itabashi-ku, 173-8610, Tokyo, Japan;Japanese Society for Dialysis Therapy Renal Data Registry Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan;

关键词: Dialysis fluid;    Diabetes;    Dialysis modality;    Glycemic control;    Hemodialysis;    Peritoneal dialysis;   

DOI  :  10.1186/s41100-020-00290-z

来源: Springer

【 摘 要 】

The annual survey questionnaires of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) were sent to 4458 dialysis facilities at the end of 2018; 4402 facilities (98.7%) responded to the facility questionnaire, and 4222 facilities (94.7%) responded to the patient questionnaire. This paper reports the results obtained in regard to several issues: dialysis fluid quality, prescription of hemodialysis and hemodiafiltration, current status of peritoneal dialysis, and glycemic indices and treatment of diabetic patients.

【 授权许可】

CC BY